M
Maria Luisa Gasparri
Researcher at University Hospital of Bern
Publications - 110
Citations - 2141
Maria Luisa Gasparri is an academic researcher from University Hospital of Bern. The author has contributed to research in topics: Cancer & Endometrial cancer. The author has an hindex of 24, co-authored 96 publications receiving 1604 citations. Previous affiliations of Maria Luisa Gasparri include University of Bern & Università telematica San Raffaele.
Papers
More filters
Journal ArticleDOI
Exosome biogenesis, bioactivities and functions as new delivery systems of natural compounds.
Ammad Ahmad Farooqi,Nishil N. Desai,Muhammad Zahid Qureshi,Daniele Rubert Nogueira Librelotto,Maria Luisa Gasparri,Maria Luisa Gasparri,Anupam Bishayee,Seyed Mohammad Nabavi,Valeria Curti,Maria Daglia +9 more
TL;DR: This review summarizes the most recent developments in exosome bioactivities and discusses the biochemical nature of exosomes and their biogenesis, and summarizes the use ofExosomes as delivery vehicles for drugs and natural compounds to the targeted site.
Journal ArticleDOI
Sentinel Node Mapping in Cervical and Endometrial Cancer: Indocyanine Green Versus Other Conventional Dyes-A Meta-Analysis.
Ilary Ruscito,Ilary Ruscito,Maria Luisa Gasparri,Maria Luisa Gasparri,Elena Ioana Braicu,Filippo Bellati,Luigi Raio,Jalid Sehouli,Michael D. Mueller,Pierluigi Benedetti Panici,Andrea Papadia +10 more
TL;DR: In cervical and endometrial cancer, ICG SLN mapping seems to be equivalent to the combination of blue dyes and 99TC in terms of overall and bilateral detection rates.
Journal ArticleDOI
PI3K/AKT/mTOR Pathway in Ovarian Cancer Treatment: Are We on the Right Track?
Maria Luisa Gasparri,Maria Luisa Gasparri,Erlisa Bardhi,Ilary Ruscito,Andrea Papadia,Ammad Ahmad Farooqi,Claudia Marchetti,Giorgio Bogani,Irene Ceccacci,Michael D. Mueller,Pierluigi Benedetti Panici +10 more
TL;DR: Ov ovarian cancer has a high recurrence rate and the low overall survival, and mTor proteins represent a potential target for inhibitors, which could ultimately play a pivotal role in counteracting cellular proliferation.
Journal ArticleDOI
Tumor infiltrating lymphocytes in ovarian cancer.
Maria Luisa Gasparri,Rukset Attar,Innocenza Palaia,Giorgia Perniola,Claudia Marchetti,Violante Di Donato,Ammad Ahmad Farooqi,Andrea Papadia,Pierluigi Benedetti Panici +8 more
TL;DR: Immune-activated tumor infiltrating lymphocytes (TILs) in ovarian tumor tissue testify that the immune system is the trigger in this neoplasm, and TILs might be considered as a potent predictive immunotherapy biomarker.
Journal ArticleDOI
Implementation of laparoscopic approach for type B radical hysterectomy: a comparison with open surgical operations
Antonino Ditto,Fabio Martinelli,Giorgio Bogani,Maria Luisa Gasparri,Violante Di Donato,Flavia Zanaboni,Domenica Lorusso,Francesco Raspagliesi +7 more
TL;DR: Laroscopic approach is a safe procedure, upholds the results of RAH, reducing invasiveness of open surgical operations, and further large prospective investigations are warranted.